“You miss every shot you don’t take.”
Marc Joiner does not treat that as just a slogan. It shapes his decisions and guides his career. Today, it forms the foundation of his work as Co-founder at Pete Pharma, where he leads pharmaceutical compounding in a new direction.
he real power is love. It’s love greater than fear,” Loren Shook says.
In a sector heavily defined by compliance and risk mitigation, Loren has built a business around a different premise. For three decades, he has challenged how the senior living industry approaches, delivers, and markets care for people living with memory loss.
Patient charts, diagnostic images, and sensitive telemetry data no longer stay within the concrete walls of the hospital. Instead, they live within complex digital networks that are constantly under threat from global actors. Because of these vulnerabilities, New York State has enacted the nation’s toughest hospital cybersecurity regulations under 10 NYCRR Section 405.46
Dentistry is going through a time when consolidation is outpacing clinical trust. Financial pressures, new ownership models, and rising technology costs are changing how practices work and how patients receive care.
In surgical settings, visibility and control shape clinical decisions. Founded in 1945 in Tuttlingen, Germany, KARL STORZ has grown from a two-person business into an international endoscopy and minimally invasive surgery company, now employing over 9,000 people worldwide
Healthcare systems face constant pressure from regulations, staffing shortages, rising costs, and emerging technology. Leaders must align care delivery with legal requirements across large regions.
Pediatric care has unique pressures. Funding models differ from adult care. Consent can involve several caregivers. Access challenges affect families in ways that don’t always match policy.
The obesity drug market is entering a new phase as pharmaceutical companies race to develop oral therapies, combination treatments and next-generation medicines. With forecasts pointing to a $100 billion annual market, competition is shifting from two dominant players to a much broader field of innovators.
Oscar Health’s latest earnings suggest the Affordable Care Act marketplace has entered a more mature and profitable phase as enrollment growth and consumer demand continue rising.
Healthcare affordability in the US is becoming an economic problem as rising costs, chronic disease and medical debt place pressure on households, employers and public budgets.
Healthcare bankruptcies are climbing again in 2026 as providers face rising labor costs, reimbursement disputes and refinancing pressure across the sector.
In oncology biotech, legal teams play a central role in advancing scientific innovation within complex regulatory and policy environments. At Exelixis, General Counsel Brenda Hefti, J.D., Ph.D., exemplifies that role by aligning legal strategy with scientific innovation and business objectives. She helps drive the delivery of therapies to patients while guiding the company through litigation, intellectual property strategy, regulatory challenges, and evolving government policy — positioning Exelixis at the critical intersection of law and science.
